XXXIX.b
XXXIX - Rechallenge
Rechallenge can lead to relapse of AE/ILD
Last update 17/06/2026
When available, likelihood and risk given for specific drug
Back
The Drug-Induced Respiratory Disease Website
Causative drugs
4
II.d
II. Myocardial dysfunction - Heart failure
II.d Cardiovascular collapse - Cardiogenic shock - Hypotension
X.b
X. Pulmonary edema
X.b Pulmonary edema, noncardiogenic (NCPE)
XXXVI.f
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.f Anaphylaxis - Anaphylactoid reaction (either of these can be fatal)
XXXVIII.m
XXXVIII. Miscellaneous - Varia
XXXVIII.m Metabolic acidosis (incl. lactic acidosis/-gap). May cause hyperpnea/dyspnea
XXXIX.a
XXXIX. Rechallenge
XXXIX.a Rechallenge can lead to near-fatal or fatal relapse of AE/ILD
XXXIX.b
XXXIX. Rechallenge
XXXIX.b Rechallenge can lead to relapse of AE/ILD
XXIV.a
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.a Pneumonitis (ILD)
XXIV.c
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.c Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)
XXXIX.b
XXXIX. Rechallenge
XXXIX.b Rechallenge can lead to relapse of AE/ILD